BrightSpring Health Services, Inc. Common Stock
NASDAQ:BTSGMedical - Healthcare Information Services
+$0.29 today
- Market cap
- $13.60B
- Beta
- 1.87
- P/E (TTM)
- 56.0
- EPS (TTM)
- $1.15
Volume 1.77M
Average 2.99M
BTSG Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
BrightSpring Health Services, Inc. Common StockNASDAQ: BTSG
Financing Cash Flow · Q3 FY2026 · quarter ended Sep 2026
Financing cash flow grows, but more slowly than its trailing trend
Q3 FY2026 financing cash flow of $13.67M (cash outflow) rose 4.3% year over year, behind the +211.2% change in trailing-twelve-month financing cash flow. Sequentially, it fell 96.1% from the prior quarter. Over 3 fiscal years it compounded at +28.8% a year.
Context
- Financing cash flow amounted to 1.2% of revenue in FY2025, down 0.2 pp from a year earlier.
- Financing cash flow increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +4.3% toward the trailing-twelve-month pace of +211.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (157.87M) USD
- Year-over-year change
- -195.9%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (157.87M) | -195.9% |
| FY2024 | 2024-12-31 | 164.65M | +314.1% |
| FY2023 | 2023-12-31 | (76.91M) | -4.2% |
| FY2022 | 2022-12-31 | (73.81M) | -110.5% |
| FY2021 | 2021-12-31 | 705.22M | — |
Financing Cash Flow vs competitors
How BTSG compares with its peers on the latest reported figures
- BTSG's LTM Sep 2026 financing cash flow of $488.32M is the 2nd largest of the 4 companies compared; the peer median is $127.85M.
- Its year-over-year change of +211.2% is the 2nd highest of 4, against a peer median of +48.2%.
- Financing cash flow amounts to 3.2% of revenue for BTSG, versus a peer median of 8.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $503.42M | +48.2% | +27.4% | 19.4% | |
| LTM Sep 2026 | $488.32M | +211.2% | +28.8% | 3.2% | |
| LTM Sep 2026 | $144.04M | -82.3% | — | 5.0% | |
| LTM Jun 2026 | $127.85M | +606.1% | — | 8.1% | |
| Peer median (excluding BTSG) | $127.85M | +48.2% | +27.4% | 8.1% | |
Competitors are the stored peer set for BTSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 51.26M | (54.22M) | (156.84M) | (20.52M) | 189.11M |
| Depreciation & Amortization | 199.16M | 203.97M | 202.34M | 204.48M | 164.28M |
| Deferred Income Tax | 6.49M | (27.96M) | (52.63M) | (25.91M) | 14.84M |
| Stock-Based Compensation | 4.52M | 3.55M | 3.92M | 69.17M | 70.1M |
| Change in Working Capital | (30.11M) | (224.47M) | 159.44M | (270.07M) | (18.54M) |
| Accounts Receivables | (93M) | (150.47M) | (127.25M) | (179.04M) | (131.29M) |
| Inventory | 4.29M | (131.83M) | 28.66M | (236.51M) | (177.91M) |
| Accounts Payables | 63.54M | 133.47M | 105.65M | 303.21M | 264.17M |
| Other Working Capital | (4.94M) | (75.63M) | 152.37M | (157.73M) | 26.48M |
| Other Non-Cash Items | 38.85M | 94.48M | 54.56M | 66.63M | 70.38M |
| Operating Cash Flow | 270.17M | (4.65M) | 210.78M | 23.77M | 490.17M |
| Capital Expenditures | (59.27M) | (70.11M) | (73.53M) | (80.91M) | (95.48M) |
| Acquisitions (Net) | (1.13B) | 113.33M | (63.06M) | (59.8M) | (204.56M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 1.7M | 2.14M | 2.15M | 473K | (5.03M) |
| Investing Cash Flow | (1.19B) | 45.36M | (134.43M) | (140.24M) | (305.08M) |
| Debt Repayment | 726.86M | (68.93M) | (66.14M) | (829.36M) | (127.12M) |
| Common Stock Issued | 12.81M | 0 | 0 | 1.05B | 25.28M |
| Common Stock Repurchased | (417K) | 0 | (650K) | (650K) | (43.17M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (34.03M) | (4.88M) | (10.12M) | (50.83M) | (12.85M) |
| Financing Cash Flow | 705.22M | (73.81M) | (76.91M) | 164.65M | (157.87M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (215.27M) | (33.11M) | (557K) | 48.18M | 27.22M |
| Free Cash Flow | 210.9M | (74.77M) | 137.26M | (57.14M) | 394.69M |
BrightSpring Health Services, Inc. Common Stock
NASDAQ:BTSG
Intrinsic Alpha fair value
Locked
Current Price
$68.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.